Clinical Trials Browser

Phase 1/2 × tivozanib × Genitourinary × Clear all

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03136627 2021-12-06

Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC

Phase 1/2 Completed

28 enrolled

Genitourinary

Carcinoma, Renal Cell

Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC